Works in Cancer Chemotherapy & Pharmacology, 2015, Vol 75, Issue 1

Results: 24

Atrial natriuretic peptide protects against cisplatin-induced acute kidney injury.

Published in:

Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 1, p. 123, doi. 10.1007/s00280-014-2624-4

By:

Nojiri, Takashi;
Hosoda, Hiroshi;
Kimura, Toru;
Miura, Koichi;
Ishikane, Shin;
Tokudome, Takeshi;
Shintani, Yasushi;
Inoue, Masayoshi;
Miyazato, Mikiya;
Okumura, Meinoshin;
Kangawa, Kenji

Publication type:

Article

Myelotoxicity after high-dose methotrexate in childhood acute leukemia is influenced by 6-mercaptopurine dosing but not by intermediate thiopurine methyltransferase activity.

Published in:

Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 1, p. 59, doi. 10.1007/s00280-014-2613-7

By:

Levinsen, Mette;
Rosthøj, Susanne;
Nygaard, Ulrikka;
Heldrup, Jesper;
Harila-Saari, Arja;
Jonsson, Olafur;
Bechensteen, Anne;
Abrahamsson, Jonas;
Lausen, Birgitte;
Frandsen, Thomas;
Weinshilboum, Richard;
Schmiegelow, Kjeld

Publication type:

Article

Phase II study of selumetinib (AZD6244, ARRY-142886) plus irinotecan as second-line therapy in patients with K-RAS mutated colorectal cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 1, p. 17, doi. 10.1007/s00280-014-2609-3

By:

Hochster, H.;
Uboha, N.;
Messersmith, W.;
Gold, P.;
ONeil, B.;
Cohen, D.;
Denlinger, C.;
Cohen, S.;
Leichman, C.;
Leichman, L.

Publication type:

Article

Predictive factors for survival in stage IIIA N2 NSCLC patients treated with neoadjuvant CCRT followed by surgery.

Published in:

Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 1, p. 77, doi. 10.1007/s00280-014-2619-1

By:

Lim, Hyun-ju;
Lee, Ho;
Lee, Kyung;
Han, Jungho;
Kwon, O.;
Park, Keunchil;
Ahn, Yong;
Kim, Byung-Tae;
Shim, Young

Publication type:

Article

A phase I, open-label, multicenter study to evaluate the pharmacokinetics and safety of oral panobinostat in patients with advanced solid tumors and varying degrees of renal function.

Published in:

Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 1, p. 87, doi. 10.1007/s00280-014-2612-8

By:

Sharma, Sunil;
Witteveen, Petronella;
Lolkema, Martijn;
Hess, Dagmar;
Gelderblom, Hans;
Hussain, Syed;
Porro, Maria;
Waldron, Edward;
Valera, Sue-zette;
Mu, Song

Publication type:

Article

A pharmacokinetic and pharmacodynamic investigation of Modufolin® compared to Isovorin® after single dose intravenous administration to patients with colon cancer: a randomized study.

Published in:

2015

By:

Wettergren, Yvonne;
Taflin, Helena;
Odin, Elisabeth;
Kodeda, Karl;
Derwinger, Kristoffer

Publication type:

journal article

Population pharmacokinetic model of ibrutinib, a Bruton tyrosine kinase inhibitor, in patients with B cell malignancies.

Published in:

Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 1, p. 111, doi. 10.1007/s00280-014-2617-3

By:

Marostica, Eleonora;
Sukbuntherng, Juthamas;
Loury, David;
Jong, Jan;
Trixhe, Xavier;
Vermeulen, An;
Nicolao, Giuseppe;
O'Brien, Susan;
Byrd, John;
Advani, Ranjana;
McGreivy, Jesse;
Poggesi, Italo

Publication type:

Article

A pharmacokinetic and pharmacodynamic investigation of Modufolin compared to Isovorin after single dose intravenous administration to patients with colon cancer: a randomized study.

Published in:

Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 1, p. 37, doi. 10.1007/s00280-014-2611-9

By:

Wettergren, Yvonne;
Taflin, Helena;
Odin, Elisabeth;
Kodeda, Karl;
Derwinger, Kristoffer

Publication type:

Article

Population pharmacokinetics of HM781-36 (poziotinib), pan-human EGF receptor (HER) inhibitor, and its two metabolites in patients with advanced solid malignancies.

Published in:

Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 1, p. 97, doi. 10.1007/s00280-014-2621-7

By:

Noh, Yook-Hwan;
Lim, Hyeong-Seok;
Jung, Jin-A;
Song, Tae;
Bae, Kyun-Seop

Publication type:

Article

Plasma pharmacokinetics and tissue and brain distribution of cisplatin in musk shrews.

Published in:

Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 1, p. 143, doi. 10.1007/s00280-014-2623-5

By:

Eiseman, Julie;
Beumer, Jan;
Rigatti, Lora;
Strychor, Sandra;
Meyers, Kelly;
Dienel, Samuel;
Horn, Charles

Publication type:

Article

Delayed methotrexate excretion in infants and young children with primary central nervous system tumors and postoperative fluid collections.

Published in:

Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 1, p. 27, doi. 10.1007/s00280-014-2614-6

By:

Wright, Karen;
Panetta, John;
Onar-Thomas, Arzu;
Reddick, Wilburn;
Patay, Zoltan;
Qaddoumi, Ibrahim;
Broniscer, Alberto;
Robinson, Giles;
Boop, Frederick;
Klimo, Paul;
Ward, Deborah;
Gajjar, Amar;
Stewart, Clinton

Publication type:

Article

Phase I study of the MEK inhibitor trametinib in combination with the AKT inhibitor afuresertib in patients with solid tumors and multiple myeloma.

Published in:

Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 1, p. 183, doi. 10.1007/s00280-014-2615-5

By:

Tolcher, Anthony;
Patnaik, Amita;
Papadopoulos, Kyriakos;
Rasco, Drew;
Becerra, Carlos;
Allred, Alicia;
Orford, Keith;
Aktan, Gursel;
Ferron-Brady, Geraldine;
Ibrahim, Nageatte;
Gauvin, Jennifer;
Motwani, Monica;
Cornfeld, Mark

Publication type:

Article

Pharmacokinetics of abiraterone in healthy Japanese men: dose-proportionality and effect of food timing.

Published in:

Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 1, p. 49, doi. 10.1007/s00280-014-2616-4

By:

Inoue, Kouichi;
Shishido, Akira;
Vaccaro, Nicole;
Jiao, James;
Stieltjes, Hans;
Bernard, Apexa;
Yu, Margaret;
Chien, Caly

Publication type:

Article

Population pharmacokinetic/dynamic model of lymphosuppression after fludarabine administration.

Published in:

Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 1, p. 67, doi. 10.1007/s00280-014-2618-2

By:

McCune, Jeannine;
Vicini, Paolo;
Salinger, David;
O'Donnell, Paul;
Sandmaier, Brenda;
Anasetti, Claudio;
Mager, Donald

Publication type:

Article

Erratum to: Phase II study of selumetinib (AZD6244, ARRY-142886) plus irinotecan as second-line therapy in patients with K-RAS mutated colorectal cancer.

Published in:

2015

By:

Hochster, H.;
Uboha, N.;
Messersmith, W.;
Gold, P.;
ONeil, B.;
Cohen, D.;
Denlinger, C.;
Cohen, S.;
Leichman, C.;
Leichman, L.;
Lenz, H.-J.

Publication type:

Erratum

Sorafenib use in elderly patients with hepatocellular carcinoma: caution about use of platelet aggregation inhibitors.

Published in:

Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 1, p. 215, doi. 10.1007/s00280-014-2645-z

By:

Edeline, Julien;
Crouzet, Laurence;
Le Sourd, Samuel;
Larible, Claire;
Brunot, Angélique;
Le Roy, Florence;
Cattenoz, Catherine;
Latournerie, Marianne;
Gédouin, Daniel;
Guillygomarc'h, Anne;
Boucher, Eveline

Publication type:

Article

Phase I trial of S-1 every other day in combination with gemcitabine/cisplatin for inoperable biliary tract cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 1, p. 191, doi. 10.1007/s00280-014-2636-0

By:

Uwagawa, Tadashi;
Sakamoto, Taro;
Abe, Kyohei;
Okui, Norimitsu;
Hata, Daigo;
Shiba, Hiroaki;
Futagawa, Yasuro;
Aiba, Keisuke;
Yanaga, Katsuhiko

Publication type:

Article

Cytoprotective and regulatory functions of glutathione S-transferases in cancer cell proliferation and cell death.

Published in:

Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 1, p. 1, doi. 10.1007/s00280-014-2566-x

By:

Singh, Simendra

Publication type:

Article

Biological evaluation of a novel sorafenib analogue, t-CUPM.

Published in:

Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 1, p. 161, doi. 10.1007/s00280-014-2626-2

By:

Wecksler, Aaron;
Hwang, Sung;
Liu, Jun-Yan;
Wettersten, Hiromi;
Morisseau, Christophe;
Wu, Jian;
Weiss, Robert;
Hammock, Bruce

Publication type:

Article

TrkB inhibition by GNF-4256 slows growth and enhances chemotherapeutic efficacy in neuroblastoma xenografts.

Published in:

Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 1, p. 131, doi. 10.1007/s00280-014-2627-1

By:

Croucher, Jamie;
Iyer, Radhika;
Li, Nanxin;
Molteni, Valentina;
Loren, Jon;
Gordon, W.;
Tuntland, Tove;
Liu, Bo;
Brodeur, Garrett

Publication type:

Article

Docetaxel, gemcitabine and bevacizumab as salvage chemotherapy for HER-2-negative metastatic breast cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 1, p. 153, doi. 10.1007/s00280-014-2628-0

By:

Kontopodis, E.;
Kentepozidis, N.;
Christophyllakis, Ch.;
Boukovinas, I.;
Kalykaki, A.;
Kalbakis, K.;
Vamvakas, L.;
Agelaki, S.;
Kotsakis, A.;
Vardakis, N.;
Georgoulias, V.;
Mavroudis, D.

Publication type:

Article

Association of ABCG2 polymorphism with clinical efficacy of imatinib in patients with gastrointestinal stromal tumor.

Published in:

Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 1, p. 173, doi. 10.1007/s00280-014-2630-6

By:

Koo, Dong-Hoe;
Ryu, Min-Hee;
Ryoo, Baek-Yeol;
Beck, Mo;
Na, Young-Soon;
Shin, Jae-Gook;
Lee, Sang;
Kim, Eun-Young;
Kang, Yoon-Koo

Publication type:

Article

EGFR-TKI is effective regardless of treatment timing in pulmonary adenocarcinoma with EGFR mutation.

Published in:

Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 1, p. 197, doi. 10.1007/s00280-014-2631-5

By:

Koo, Dong-Hoe;
Kim, Kyu-pyo;
Choi, Chang-Min;
Lee, Dae-Ho;
Lee, Jae;
Lee, Jung-Shin;
Jang, Se;
Kim, Sang-We

Publication type:

Article

Effects of CYP2B6 genetic polymorphisms in patients receiving cyclophosphamide combination chemotherapy for breast cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 1, p. 207, doi. 10.1007/s00280-014-2632-4

By:

Haroun, F.;
Al-Shaar, L.;
Habib, R.;
El-Saghir, N.;
Tfayli, A.;
Bazarbachi, A.;
Salem, Z.;
Shamseddine, A.;
Taher, A.;
Cascorbi, I.;
Zgheib, N.

Publication type:

Article